Article Information
History
- June 26, 2024.
Article Versions
- Version 1 (June 25, 2024 - 21:12).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Nicholas J. Shaheen, MD, MPH1,
- Mohamed O. Othman, MD2,
- Jawar Taunk, MD3,
- Kenneth J. Chang, MD4,
- Sathya Jaganmohan, MD5,
- Patrick S. Yachimski, MD6,
- John C. Fang, MD7,
- Joseph S. Spataro, MD8,
- Suman Verma, MD, PhD9,
- Victoria T. Lee, MD9,*,
- Brian J. deGuzman, MD9 and
- Lishan Aklog, MD9
- 1Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
- 2Gastroenterology and Hepatology Section, Baylor College of Medicine, Houston, TX, USA
- 3Advanced Gastroenterology Associates, Palm Harbor, FL, USA
- 4University of California, Irvine Medical Center, Orange, CA, USA
- 5Louisiana Research Center, Shreveport, LA, USA
- 6Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt University Medical Center, Nashville, TN, USA
- 7Division of Gastroenterology, Hepatology and Nutrition, University of Utah, Salt Lake City, Utah, USA
- 8Central Virginia VA Health Care System, Richmond, VA, USA
- 9Lucid Diagnostics Inc., New York, NY, USA
- ↵*Corresponding author; email: vtl{at}pavmed.com
Posted June 26, 2024.
Use of the EsoGuard® Molecular Biomarker Test in Non-Endoscopic Detection of Barrett’s Esophagus among High-Risk Individuals in a Screening Population
